Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- CheckyesterdayChange DetectedA new footer revision tag 'Revision: v3.6.3' was added; several navigation/related items were removed, including 'Type 2 diabetes', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.2'.SummaryDifference0.1%

- Check8 days agoChange DetectedType 2 diabetes was added to the related topics and MedlinePlus Genetics was added as a related topic; the revision tag updated from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page’s condition label and related topics section have been shortened by removing 'Type 2 diabetes', the related topics header, and 'MedlinePlus Genetics', altering what is surfaced to users about the condition and related resources.SummaryDifference0.1%

- Check22 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed for this study. The page also adds new help and navigation content ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and related topic links, while the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check30 days agoChange DetectedThe page now displays the latest site revision, 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. It also removes references to 'Type 2 diabetes' and 'related topics: MedlinePlus Genetics'.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now includes additional related-topic links for Type 2 diabetes and MedlinePlus Genetics under the related topics section, expanding access to diabetes and genetics resources.SummaryDifference0.1%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.